Star Micronics launches TSP100IV POS printer
High Wycombe, UK, 8 March 2022 International POS printer manufacturer Star Micronics announces the launch…
High Wycombe, UK, 8 March 2022 International POS printer manufacturer Star Micronics announces the launch…
We Want To Announce An Automotive Artist-Led Initiative To Create A Charitable Response To The…
By Andrew Gogarty (Chief Security Evangelist) With much of the UK workforce now heading back…
By Nick Allen, Managing Director, 3DPRINTUK The uses of 3D printing today are well established…
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced…
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company…
WAYNE, Pa. and ROCKVILLE, Md., March 08, 2022 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:…
GAITHERSBURG, Md., March 08, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
REDWOOD CITY, Calif., March 08, 2022 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics (Nasdaq: PRCT) (the “Company”),…
First data from preclinical synthetic lethality program of novel VPS4A inhibitors with potential for clinical…
Company reports fourth quarter and full year 2021 XHANCE net revenue of $22.5 million and…
Good Supply Hash Bats Educational overview of a Hash Bat. TORONTO, March 08, 2022 (GLOBE…
Revenue up 7% year-over-year as sales momentum continues, despite global supply chain headwinds Gross margin…
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology…
Fireside Chat scheduled for Tuesday, March 15, 2022, at 9:30 a.m., PT BOCA RATON, Fla.,…
Presentation Evaluates Efficacy of D-PLEX100 in Reducing Surgical Site Infection Rates in Elective Colorectal Surgery…
The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on…
Sanjay Keswani, MBBS, FRCP Sanjay Keswani, MBBS, FRCP Lynne Murray, Ph.D., MBA Lynne Murray, Ph.D.,…
— EB613 expected to commence pivotal Phase 3 Osteoporosis trial in 2022 —— New EB612…
– Fifteen Patients Enrolled to Date in Cohort 4 of EnACT (all oral induction regimen);…